Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

801.65 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
99 100 Next >
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
From FN Media Group LLC
Via GlobeNewswire
Spotlight on Eli Lilly: Analyzing the Surge in Options Activity
Via Benzinga
Investing in This Healthcare Stock Could Be Like Catching Nvidia at the Dawn of the AI Boom
Nvidia has been the hottest stock since the start of the AI revolution, and I see one particular healthcare business following a similar trajectory. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split)
History shows that Eli Lilly tends to do something special with its stock toward the end of the year. 
Via The Motley Fool
In-Depth Analysis: Eli Lilly Versus Competitors In Pharmaceuticals Industry
Via Benzinga
Looking Into Eli Lilly's Recent Short Interest
Via Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
Via Benzinga
Netflix, Eli Lilly Lead 5 Fast Growers Near Buy Points
NFLX is among four stocks on the list that's actionable now. 
Via Investor's Business Daily
Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today
The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout. 
Via The Motley Fool
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
FTC files a complaint against CVS, Cigna, and UnitedHealth's PBMs, accusing them of inflating insulin prices through a rebate-driven system. The case aims to address unfair practices and improve access... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules
Eli Lilly appeals a $183 million judgment in a Medicaid fraud case, arguing that it followed a reasonable interpretation of the law. The case has drawn attention from major business and pharmaceutical... 
Via Benzinga
Topics Fraud
Exposures Legal
6 Incredible Reasons to Invest in Eli Lilly
The drug giant's winning ways look set to continue for a while. 
Via The Motley Fool
Looking At Eli Lilly's Recent Unusual Options Activity
Via Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
Via Benzinga
Why Tandem Diabetes Care Stock Thrashed the Market Today
At a stroke, it's got a product authorized for a specific use in 27 countries. 
Via The Motley Fool
2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure?
Pharma stock have been on the rise in the latter half of the year, but the 2024 election remains a wild card for shares. 
Via Investor's Business Daily
1 Unstoppable Stock That Could Join the $1 Trillion Club in 2025
Eli Lilly stock may look expensive, but that may not be the case in a few years as the business grows at a rapid pace. 
Via The Motley Fool
Prediction: This Will be Eli Lilly's Next Big Move.
Lilly could take a step that's positive for the stock and investors over the long term. 
Via The Motley Fool
Why ResMed Stock Tumbled by 5% Today
A looming threat from a very powerful rival could significantly dampen a key business for the company. 
Via The Motley Fool
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments
Terns has a modest market cap of less than $800 million, and its possible upside could be massive. 
Via The Motley Fool
ADX: A High-Yielding, Diversified CEF Worth Looking Into
When it comes to investing, there are two critical “bedrocks” we need to keep in mind. These two facts are why 95% of my favorite high-income investments, closed-end funds (CEFs), have made investors... 
Via Talk Markets
Prediction: This Will Be the First Healthcare Stock to Join the Trillion-Dollar Club
Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the door of a trillion-dollar valuation. 
Via The Motley Fool
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
Telemedicine once seemed like it was going to revolutionize healthcare. 
Via The Motley Fool
Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss
The FDA has approved Eli Lilly's Ebglyss for moderate-to-severe eczema in patients 12 and older. The treatment is administered via monthly injections and demonstrated clear skin and itch relief in... 
Via Benzinga
Exposures Product Safety
Kalm Therapeutics Hires Former GSK Director Dr. Tomoko Maeda-Chubachi as Chief Medical Officer
Huntsville, Alabama--(Newsfile Corp. - September 16, 2024) - Kalm Therapeutics (Kalm Tx) is pleased to announce the appointment of Dr.... 
Via Newsfile
3 Stocks to Buy and Hold Forever
These stocks are built for the long run. 
Via The Motley Fool
Time To Invest And Or Trade In Bio-Tech Stocks?
Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help... 
Via Talk Markets
Topics ETFs
Stock Market Rally Revives; Apple iPhone 16, Nvidia, Oracle, Adobe In Focus: Weekly Review
The major indexes reclaimed key levels and many leaders flashed buy signals. 
Via Investor's Business Daily
Eli Lilly Pumps $800M Into Irish Operations To Meet Skyrocketing Demand For Mounjaro, Zepbound
The investment is aimed at ensuring a steady supply of the drugs, which have been grappling with shortages since 2022. 
Via Benzinga
Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now
Amgen is a decently valued stock that has an excellent business and also gives investors a way to potentially gain exposure to a lucrative weight loss market. 
Via The Motley Fool
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.